Why this question matters
A named amino acid in a proprietary formula is not the same as a known clinical-trial dose.
A quality decision should be based on a verified label and reliable clinical information rather than only a product landing page or anecdotal success story.
Individual dosing changes interpretation
Boostaro names L-citrulline, but the accessible secondary blend panel does not state its separate dose. The entire five-component blend is reported as 725 mg.
An ingredient trial using a measured citrulline amount cannot be mapped directly onto an unspecified fraction of a proprietary blend.
What to check first
Identify which statements are seller descriptions, which come from a physical label and which result from controlled research. In particular, a marketing page may cite a pathway such as nitric-oxide signaling without establishing a finished-formula health outcome.
Ask whether a claim involves a well-defined population, dose, control group and validated clinical measurement.
How it relates to Boostaro
The checked Boostaro /long campaign lists seven main ingredients, 60 capsules, one/three/six-bottle offers and a 60-day guarantee. A secondary Boostaro-branded label groups five actives in a total proprietary blend.
Its strong claims about fixing ED should not be confused with medical evidence for an individual patient or with professional evaluation of circulatory, metabolic and psychological factors.
Safe and useful next steps
Confirm the actual checkout total and written return instructions, request a physical Supplement Facts panel and review your medicines with a qualified professional.
If you have persistent ED, new cardiovascular symptoms or take anticoagulants, seek appropriate medical guidance rather than relying on an online supplement claim.
A decision framework
Compare similar products by actual per-serving active ingredient amounts, not solely by ingredient names or the lowest advertised bottle price.
Keep reviews, testimonials and any bonus ebooks separate from independently validated clinical evidence.
Sources and editorial verification
We checked the user-provided official sales campaign on November 9, 2026. Where amounts come from a separate Boostaro-branded label page, that source is identified explicitly. Ingredient or disease research is not an endorsement of Boostaro.
- Boostaro official /long/ sales campaign, checked November 9, 2026
- NIDDK: Erectile Dysfunction overview
- NIDDK: Treatment for Erectile Dysfunction
- Memorial Sloan Kettering: Nattokinase safety
- NIH Office of Dietary Supplements: Vitamin K
- FDA: Dietary supplement information for consumers
- FTC: Health Products Compliance Guidance